According to FMI: By 2022, the cancer tissue diagnostics market is projected to be worth US$ 5.3 billion, growing at a moderate CAGR of 6.6% between 2022 and 2032. By 2032’s end, the market for cancer tissue diagnostics is projected to be worth around US$10.04 billion.
FMI’s report titled “Cancer Tissue Diagnostics Market: Global Industry Analysis and Opportunity Assessment 2016–2026 ” also cites that North America represents the most lucrative market for cancer tissue diagnostics, followed by Europe and APAC. In 2016, North America accounted for more than 36% share of the global market. The cancer tissue diagnostics market in this region is expected to reach a valuation of US$ 4,017.7 Mn towards the end of 2026.
Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4191
This growth is primarily attributed to factors such as the constantly extending list of cancer biomarkers and the presence of advance healthcare infrastructures in the region. Meanwhile, Asia Pacific excluding Japan (APEJ) is also anticipated to witness a strong growth of its market over the next couple of years. By 2026-end, the region’s market is expected to reach US$ 1,107.7 Mn in terms of revenue.
The report further projects that in situ hybridization will continue to be the leading cancer tissue diagnostics type. In terms of revenue, in situ hybridization tests are projected to account for the largest share of the market during the assessment period. Cases of breast cancer have been quite high amongst all the cancers type of late. Hence, procedures for breast cancer diagnostics are expected to remain relatively higher than for other cancer types in 2017 and beyond.
Key Factors Boosting the Global Cancer Tissue Diagnostics Market Include:
- Inclusion of cancer screening tests in national cancer screening programs in various countries.
- Havier discretionary funding for cancer research that is resulting in the development of more efficient diagnostic procedures.
- Arrival of revolutionary second and third -generation diagnostics platforms that are quickly gaining popularity in the market.
- Novelty in imaging techniques and availability of affordable diagnostics.
Key Players:
Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Ventana Medical Systems, Inc, Bio Rad Laboratories Inc., Enzo Life Sciences, Inc., Abcam plc., BioGenex, Cell Signaling Technology, Inc., Agilent Technologies, Inc., PerkinElmer Inc. are some of the prominent companies operating in the global market for cancer tissue diagnostics.
Ask An expert here@ https://www.futuremarketinsights.com/askus/rep-gb-4191
Many of these market players are implementing merger and acquisition strategies to increase their market presence. Furthermore, cancer diagnostic assay kits developers, instrument manufacturers and technology license providers are also partnering with each other in order to increase their consumer base.
Cancer Tissue Diagnostics Market – Segmentation by Category
Test Type:
- Immunohistochemical (IHC) Test
- Breast Cancer
- Stomach (Gastric) Cancer
- Colorectal Cancer
- Prostate Cancer
- Others
Request for Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-4191
- In Situ Hybridization (ISH) Test
- Breast cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Bladder Cancer
- Others
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape
Ambulatory Surgical Centres Market
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
The post Cancer Tissue Diagnostics Market is projected to grow at a prolific CAGR of 6.6% totaling US$ 10.04 Bn during the forecast period of 2022-32 | Get Insights FMI appeared first on Future Market Insights.
